PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $258,000 | +2.8% | 100,400 | 0.0% | 0.00% | – |
| Q4 2020 | $251,000 | +20.7% | 100,400 | 0.0% | 0.00% | – |
| Q3 2020 | $208,000 | -33.1% | 100,400 | 0.0% | 0.00% | – |
| Q2 2020 | $311,000 | +314.7% | 100,400 | +203.3% | 0.00% | – |
| Q1 2020 | $75,000 | -37.5% | 33,100 | 0.0% | 0.00% | – |
| Q4 2019 | $120,000 | -33.0% | 33,100 | -6.2% | 0.00% | – |
| Q2 2018 | $179,000 | – | 35,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |